TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.

Antonio Llombart-Cussac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.